Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Po...
Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study
About this item
Full title
Author / Creator
Publisher
United States: Wolters Kluwer
Journal title
Language
English
Formats
Publication information
Publisher
United States: Wolters Kluwer
Subjects
More information
Scope and Contents
Contents
Proton pump inhibitors (PPIs) are commonly prescribed medications. Long-term use of PPIs has been suspected to have a provocative effect on gastric cancer. This study was to determine the association between PPI vs histamine 2 receptor antagonist (H2RA) use and the risk of gastric cancer in a region where the risk of this malignancy is high.
A p...
Alternative Titles
Full title
Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2554961703
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2554961703
Other Identifiers
ISSN
0002-9270
E-ISSN
1572-0241
DOI
10.14309/ajg.0000000000001167
